Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy?
Following the company's first-quarter earnings report, shares of Hims & Hers Health (NYSE: HIMS) opened the following day considerably lower, only to sprint higher once trading began. This action is just one example of why the stock is a bit of a divisive name among investors. This can also be seen in its high short interest, which sits above 25%.The stock is up around 108% year to date (as of this writing), while at the same time it's down about 27% from the highs it set earlier this year. Let's take a closer look at the telehealth company's recent results and shocking long-term guidance to see where Hims & Hers stock may be headed next.Hims & Hers' Q1 earnings report highlighted both the strengths of the company and the reasons many investors remain skeptical.Continue reading
Following the company's first-quarter earnings report, shares of Hims & Hers Health (NYSE: HIMS) opened the following day considerably lower, only to sprint higher once trading began. This action is just one example of why the stock is a bit of a divisive name among investors. This can also be seen in its high short interest, which sits above 25%.
The stock is up around 108% year to date (as of this writing), while at the same time it's down about 27% from the highs it set earlier this year. Let's take a closer look at the telehealth company's recent results and shocking long-term guidance to see where Hims & Hers stock may be headed next.
Hims & Hers' Q1 earnings report highlighted both the strengths of the company and the reasons many investors remain skeptical.
